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Summary
Objective: Status epilepticus (SE) is an abnormally prolonged epileptic seizure that if
associated with convulsive motor symptoms is potentially life threatening for a patient.
However, 20%-40% of patients with SE lack convulsive events and instead present
with more subtle semiology such as altered consciousness and less motor activity.
Today, there is no general consensus regarding to what extent nonconvulsive SE
(NCSE) is harmful to the brain, which adds uncertainty to stringent treatment regimes.
Methods: Here, we evaluated brain pathology in an experimental rat and mouse
model of complex partial NCSE originating in the temporal lobes with Western
blot analysis, immunohistochemistry, and ex vivo diffusion tensor imaging (DTI).
The NCSE was induced by electrical stimulation with intrahippocampal electrodes
and terminated with pentobarbital anesthesia. Video-electroencephalographic
recordings were performed throughout the experiment.
Results: DTI of mice 7 weeks post-NCSE showed no robust long-lasting changes
in fractional anisotropy within the hippocampal epileptic focus. Instead, we found
pathophysiological changes developing over time when measuring protein levels
and cell counts in extracted brain tissue. At 6 and 24 hours post-NCSE in rats, few
changes were observed within the hippocampus and cortical or subcortical struc-
tures in Western blot analyses of key components of the cellular immune response
and synaptic protein expression, while neurodegeneration had started. However,
1 week post-NCSE, both excitatory and inhibitory synaptic protein levels were
decreased in hippocampus, concomitant with an excessive microglial and astrocytic
activation. At 4 weeks, a continuous immune response in the hippocampus was
accompanied with neuronal loss. Levels of the excitatory synaptic adhesion mole-
cule N-cadherin were decreased specifically in rats that developed unprovoked
spontaneous seizures (epileptogenesis) within 1 month following NCSE, compared
to rats only exhibiting acute symptomatic seizures within 1 week post-NCSE.
Significance: These findings provide evidence for a significant brain pathology
following NCSE in an experimental rodent model.
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1 | INTRODUCTION
Status epilepticus (SE) is a severe neurological condition
characterized by prolonged seizure activity that may be
fatal if not interrupted. It typically manifests with convul-
sive movements, but 20%-40% of SE cases present a more
heterogeneous semiology referred to as nonconvulsive SE
(NCSE).1–3 Common clinical manifestations of NCSE are
altered consciousness, automatisms, and subtle motor activ-
ity such as lip smacking or stereotypic orofacial/hand/arm
movements, and they often involve the frontotemporal
brain regions.1,4 NCSE can be difficult to diagnose, espe-
cially in comatose patients.
Convulsive SE for >30 minutes, regardless of the trigger-
ing factor, can be fatal and leads to substantial neuronal
death in the brain. To what extent NCSE, which may either
be cryptogenic or arise due to other brain insults, could injure
the brain is not clear. So far, the general clinical prediction of
NCSE is that it may not give rise to long-lasting changes in
the brain. Magnetic resonance imaging (MRI), single photon
emission computed tomography, and diffusion tensor imag-
ing (DTI) of patients with ongoing NCSE have shown peri-
ictal abnormalities including regional hyperperfusion and
reduced diffusion, but on follow-up MRI most patients show
complete resolution.5,6 Consequently, when considering
aggressive anesthetic therapy to terminate drug-resistant
NCSE the clinical knowledge of possible brain injuries due
to the NCSE per se is lacking and the treatment is mostly
dependent on the underlying disease.1
A number of experimental animal models have been uti-
lized to study disease mechanisms of SE, with the chemical
pilocarpine/kainic acid models being the most frequently
used.7–10 Electrical stimulation with intracranial electrodes
to generate an epileptic focus is also a well-established
model.11 Primarily, these models are used to induce sec-
ondary generalized and convulsive seizures. There is a lack
of extensive experimental studies defining significant
NCSE-induced brain pathology.
The pathophysiology that follows upon prolonged con-
vulsive seizures involves a disruption of the common bal-
ance between excitatory and inhibitory neuronal pathways,
which are normally regulated by a number of proteins
within the neuronal synapses, including adhesion molecules
and scaffolding proteins such as neuroligins and cad-
herins.12,13 The latter are important for spine shape, synap-
tic establishment, transmission, and strength, and thus
network excitability.13,14 Synaptic dysregulation is closely
related to both neuronal death and glial activation.15,16
How the levels of synaptic proteins may change in the
brain following NCSE is hardly known.
In the current study, we utilize a protocol for NCSE
originating from the temporal lobes, induced by electrical
stimulation.11,17 We describe semiology and electroen-
cephalographic (EEG) pattern during NCSE, the degree of
acute symptomatic and spontaneous seizures, and interictal
activity (IA) post-NCSE. We investigate whether DTI
detects robust long-lasting structural changes in the brain
and whether neuronal loss, immune reaction, and alter-
ations in synaptic proteins may be detectable in brain tissue
at several time points post-NCSE.
2 | MATERIALS AND METHODS
2.1 | Animals
Adult male Sprague-Dawley rats (n = 85) weighing 200-
250 g and male C57/BL mice (n = 6) were procured from
Charles River (Sulzfeld, Germany) and housed with a 12-hour
light/dark cycle and ad libitum food and water. Experimental
procedures followed guidelines set by the Malm€o-Lund Ethi-
cal Committee in Sweden for use and care of laboratory ani-
mals. Every effort was made to limit the number of animals
used. ARRIVE (Animal Research: Reporting of In Vivo
Experiments) guidelines were considered when planning the
experiments. Animals were randomly divided into the differ-
ent experimental groups and analyzed by researchers who
were blind to the treatment condition. Male rats and mice were
used to compare data with a previous similar epilepsy
model.17,18
2.2 | Group assignment
Rats were divided into 4 survival groups following electri-
cally induced NCSE and corresponding electrode-implanted
nonstimulated controls (Ctrl): 6 hours (NCSE, n = 7; Ctrl,
n = 8), 24 hours (NCSE, n = 11; Ctrl, n = 11), 1 week
(NCSE, n = 6; Ctrl, n = 6), 4 weeks (NCSE, n = 16; Ctrl,
n = 12). At 4 weeks, a subset of rats had developed spon-
taneous recurrent seizures (n = 12) whereas others only
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displayed acute symptomatic seizures during the 1 week
following NCSE (n = 4). Immunohistochemical analyses
were performed on a separate group of rats at 4 weeks fol-
lowing NCSE. These animals also had an implanted ante-
rior intraventricular cannula, ipsilateral to the electrode
(NCSE, n = 6; Ctrl, n = 9) and serve as Ctrl in a separate
project (Avdic et al, unpublished observations). Six mice
(Ctrl, n = 3; NCSE, n = 3) were used for DTI.
2.3 | Electrically induced NCSE
Animals were anesthetized with 1.5%-2% isoflurane and
implanted with a bipolar insulated stainless steel electrode
(Plastics One, Roanoke, VA, USA) into the right ventral
CA1/CA3 region of the hippocampus (HPC; coordinates in
rats: 4.8 mm posterior, 5.2 mm lateral from bregma, and
6.3 mm ventral from dura, tooth bar = 3.0 mm; coordi-
nates mice: 2.9 mm posterior, 3.0 mm lateral from bregma,
and 3.0 mm ventral from dura, tooth bar = 3.0 mm) for
stimulation and recording. A unipolar electrode was placed
between the skull and adjacent muscle to serve as ground
electrode. Following 1 week of recovery after surgery, ani-
mals were subjected to 1 hour of electrical stimulation
according to a previously described protocol.17 Only animals
that after 1 hour of stimulation displayed self-sustained ictal
EEG activity for 2 hours with mainly complex partial seizure
semiology, including immobility, stereotypic hyperactive
explorative behavior without reacting to sudden sounds such
as clapping, orofacial twitches, head nodding, drooling, and/
or unilateral forelimb clonus, were included. Behavioral
symptoms and ictal EEG activity were interrupted after
2 hours of self-sustained NCSE by administration of pento-
barbital (65 mg/kg, intraperitoneal injection; Figure 1).
2.4 | EEG evaluations
Animals were continuously video-EEG–monitored (24 h/d)
throughout the experimental procedure (Powerlab and Lab-
chart v8.1.1; AD Instruments, Dunedin, New Zealand; sam-
pling frequency = 1000 Hz). The EEG from
intrahippocampal electrodes was visually evaluated and
quantified in terms of EEG patterns during NCSE, number
of spontaneous and acute symptomatic seizures, and IA.
Seizures (both acute symptomatic, which occur within 1
week after NCSE, and spontaneous, starting day 8 post-
NCSE)19,20 were defined as epileptiform EEG activity last-
ing ≥10 seconds with an evolving pattern, typically consist-
ing of initial high-frequency low-amplitude activity that
over time increases in amplitude and decreases in fre-
quency as a spike–slow-wave pattern. Seizure frequency
was quantified manually, and the total time animals exhib-
ited seizure activity was divided into days 0-7 and 8-28
post-NCSE. IA was graded according to a 0-5 scale
(0 = none, 1 = <10 spikes/h, 2 = approximately 50 spikes/
h, 3 = approximately 80 spikes/h, 4 = approximately 100
spikes/h, and 5 = >150 spikes/h).
2.5 | Tissue preparation
For DTI, mice were anesthetized and transcardially per-
fused with 0.9% saline for 3 minutes, followed by 4%
paraformaldehyde for 15 minutes, before decapitation.
Intact heads were postfixed overnight and washed with
0.9% saline for >12 hours. Prior to imaging, heads were
placed in perfluoro polyether (Galden HS240; Vacuumser-
vice Oy, Helsinki, Finland) to prevent drying and suppress
background signal.
For biochemical analyses, rats were decapitated and
brains were immediately removed, divided into ipsilateral
and contralateral hemispheres related to electrode implanta-
tion, further dissected into HPC, cortex, and subcortex, fro-
zen on dry ice, and stored at 80°C. Homogenization and
determination of protein concentration were performed as
previously described.21
Details on immunohistochemical processing, Fluoro-
Jade (FJ) and hematoxylin-eosin (H&E) stainings and cell
counts can be found in the supporting information.
2.6 | Diffusion tensor imaging acquisition,
data processing, and data analysis
Mouse brains were imaged ex vivo in a 9.4-T magnet
(Oxford Instruments, Abingdon, UK). Details on acquisi-
tion parameters are provided in the supporting information.
A voxelwise fit of the diffusion tensor model was per-
formed to generate fractional anisotropy (FA) maps. FA
maps were analyzed using in-house built-in MATLAB soft-
ware (AEDES; http://aedes.uef.fi). In FA maps, 3 adjacent
images at 2.92 mm posterior from bregma were analyzed.
Two regions of interest (ROIs) within the epileptic focus
were manually marked; dorsal molecular layer (dML) of
the supragranular blade of the dentate gyrus in HPC, with
no visually observed blurriness, and the ventral CA3 region
with visual blurriness (Figure 1C).
2.7 | Western blot analysis
Western blot analysis was performed as previously
described.22 For a detailed list of primary antibodies (Abs)
see Table S1. Secondary Abs used were either horseradish
peroxidase–conjugated antimouse (1:5000), antigoat
(1:5000), or antirabbit (1:5000; Sigma, St. Louis, MO, USA).
Band intensities were quantified using ImageJ software. Rela-
tive protein expression was compared to the control levels
and normalized by expression of internal control b-actin or
glyceraldehyde-3-phosphate dehydrogenase levels.








FIGURE 1 Intrahippocampal electroencephalogram recordings, diffusion tensor imaging (DTI), and histopathology of rodent brain following
nonconvulsive status epilepticus (NCSE). A, Representative background activity before stimulation (baseline), epileptiform afterdischarge during
1 hour of stimulation, epileptiform activity with varying frequency during 2 hours of self-sustained complex partial NCSE, and background
activity during and after waking up from anesthesia when NCSE was terminated with pentobarbital injection, an example of a spontaneous
seizure with evolving pattern, and interictal epileptiform activity. B, Pie chart showing the mean percentage of time exhibiting nonconvulsive or
convulsive seizure semiology during 2 hours of NCSE. C-E, Representative DTI images of nonstimulated control mice (Ctrl) and 7 weeks post-
NCSE. C, Regions of interest for fractional anisotropy analysis in CA3 (green) and dorsal molecular layer (ML) of dentate gyrus (red)
contralateral to electrode implantation. Arrow in E marks occasional structural disruption in ventral CA3 of NCSE mice and arrowhead points at
the tissue damage due to the electrode. Insets in D and E show higher-magnification of hematoxylin-eosin (Htx-Eosin) staining in CA3. Note the
clustering of small cell nuclei (arrows) in E. F, G, Representative images of hippocampus in hematoxylin-eosin staining from Ctrl (F) and NCSE
(G) and panel of high-magnification of CA1, CA3, and granular cell layer (GCL). Dotted lines mark area and examples of width for
measurements of layer thickness. H, I, and J, K NeuN- and Iba1-positive cells included in stereological counting in CA1 and CA3 7 weeks post-
NCSE, respectively. L, M, Quantification of relative percentage and microphotographs of Iba1-positive cells with different morphologies,
including ramified (RAM), intermediate (INTER), and round/amoeboid (R/A). Scalebar in D represents 25 lm, F represents 500 lm, in H
represents 10 lm in H and J, in I represents 10 lm in I and K, and in M represents 10 lm
948 | AVDIC ET AL.
2.8 | Statistical analysis
Statistical analyses were performed with unpaired and
paired Student t tests when comparing 2 groups, using
GraphPad (La Jolla, CA, USA) Prism software. Interictal
analysis, grading of FJ+ cells, and stereology of Iba1 and
NeuN in mice (n = 3) were analyzed with nonparametric
Mann-Whitney test, the latter due to nonnormal distribution
of numbers. Data are presented as mean  standard error
of mean or median  range, unless otherwise stated. Dif-
ferences were considered statistically significant at P ≤ .05.
3 | RESULTS
3.1 | EEG and semiology of NCSE and the
development of spontaneous seizures in rats
After 1 hour of electrical stimulation of the right HPC, all
included rats exhibited self-sustained seizure activity for
2 hours, confirmed by continuous epileptiform EEG activ-
ity, and nonconvulsive seizure semiology (94% of the time,
<6% of the time convulsive semiology with bilateral fore-/
hindlimb clonus; Figure 1A,B). Intraperitoneal anesthesia
was used to interrupt ictal activity. The EEG patterns dur-
ing NCSE included the most common pattern found in
clinical practice: periodic rhythmic discharges of low fre-
quencies (1-3 Hz), with or without polyspike formations,
mixed with periods of evolving buildup of a rhythmic
high-frequency pattern (Figure 1A).3,23,24
Following NCSE, in total 88% of all rats experienced
acute symptomatic seizures (100% in 6 hours, 67% in
24 hours, 83% in 1 week, and 93% in 4 weeks group).
Of the 93% in the 4-week group, 29% exhibited only
acute symptomatic, whereas 71% developed both acute
symptomatic and spontaneous seizures. A subset of rats in
the 4-week group (35%) regained their NCSE within
5 hours after anesthesia, of which 30% exhibited only acute
symptomatic, whereas 60% also developed spontaneous sei-
zures. The mean duration of the regained NCSE measured
338  72.7 minutes, and the vast majority self-terminated.
The rest received a second anesthesia and were terminated
permanently. The mean total duration of all EEG-verified
spontaneous seizures per rat during weeks 2-4 in the
4-week survival group measured 32  12 minutes,
whereas their total load of acute symptomatic seizures dur-
ing the first week post-NCSE was 10.2  2.6 minutes.
Rats with only acute symptomatic seizures exhibited an
ictal load of 3.6  1.6 minutes, which did not differ
significantly from rats with spontaneous epileptic seizures.
The spontaneous seizures consisted of both nonconvulsive
(majority) and convulsive semiology.
Interictal grading (amount of interictal epileptiform
activity) of the EEG from the 4-week survival group
showed no differences between rats with spontaneous and
only acute symptomatic seizures during the first week post-
NCSE (2.6  0.30 vs 2.0  0.2) or during weeks 2-4
(2.4  0.3 vs 2.0  0.3, where grade 2 was defined as
approximately 50 spikes/h). The NCSE rats experienced no
weight loss compared to Ctrl at 4 weeks post-NCSE (Ctrl
426.4  14.4 g vs NCSE 421.3  11.4 g).
3.2 | DTI analysis of mouse brain 7 weeks
after NCSE
DTI is an MRI-based imaging technique that detects water
diffusion and enables measurement of microstructural alter-
ations in the tissue. We have previously demonstrated
epileptic insults after kainic acid–induced convulsive SE.25
Visual assessment on DTI maps of the epileptic focus in
the temporal lobe after NCSE (Figure 1C-E) indicated a
disrupted integrity of the ventral HPC layers contralateral
to the electrode-implanted side (Figure 1D, arrow) in a
small group of mice 7 weeks post-NCSE. However, quanti-
tative analysis of FA in the contralateral ventral CA3 and
dML showed no significant differences compared to Ctrl
(CA3: Ctrl 0.19  0.02 vs NCSE 0.22  0.01; dML: Ctrl
0.33  0.06 vs NCSE 0.35  0.02). When evaluating the
cytoarchitecture of the contralateral HPC with H&E stain-
ing, no differences in gray layer thickness were observed,
suggesting that no robust cell layer dispersion had occurred
(Figure 1F,G, Table S2). The density of NeuN+ and Iba1+
cells was not different (Figure 1H-K, Table S2). Due to
high variation in numbers of Iba1+ cells in CA1/CA3 of
the NCSE group, we also analyzed the morphology of
Iba1+ cells in these regions and found a difference in the
percentage of phenotypes, where the NCSE group had rela-
tively less ramified/surveying compared to more activated
intermediate/round/amoeboid Iba1+ cells (Figure 1L,M).
Due to electrode disturbances, ROI analyses were not per-
formed for ipsilateral HPC. The NCSE mice exhibited sim-
ilar EEG patterns and semiology during NCSE as rats, with
98.5% nonconvulsive semiology and continuous epilepti-
form EEG activity during 2 hours. No continuous video-
EEG was performed during the 7 weeks post-NCSE;
hence, the mice could not be further divided into acute
symptomatic or epileptogenic animals.
3.3 | Neuronal loss and glial activation within
the epileptic focus following NCSE in rats
Because our cohort of DTI-imaged mice supported the clin-
ical experiences of the difficulties in detecting robust long-
lasting structural changes due to NCSE, we continued to
evaluate possible biochemical tissue alterations, such as
protein levels representative of neuronal loss and immune
reactions. The amounts of neurons (NeuN), microglia
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(Iba1), and astrocytes (glial fibrillary acidic protein
[GFAP], S100b) were analyzed in cortical, subcortical, and
HPC tissue 6 and 24 hours, and 1 and 4 weeks post-NCSE
(Figure 2A-E). Due to possible local damage inflicted by
the intraparenchymal electrodes, ipsilateral HPC and con-
tralateral HPC were analyzed separately. At 6 hours post-
NCSE, total protein levels of NeuN (Figure 2A), Iba1,
GFAP, and S100b remained unchanged in contralateral
HPC (Table S4). No changes were detected in ipsilateral
HPC, cortex, and subcortex, except for an increase in
GFAP in subcortical structures (Table 1). At 24 hours fol-
lowing NCSE, a common time point when the pathophysi-
ology starts to manifest after convulsive seizures,26 we
detected region-specific FJ+ labeling particularly in CA1
and CA3 (Figure 2B), whereas there was no significant dif-
ference in the dentate hilus (Ctrl 3.1  0.8 vs NCSE
7.9  3.4 cells/section). Despite ongoing neurodegenera-
tion, analyses showed no alterations in NeuN protein levels
in ipsilateral and contralateral HPC tissue (Figure 2A,
Table 1). Similarly, Iba1 and GFAP levels remained
unchanged whereas S100b increased slightly in contralat-
eral HPC (Table S4). No changes were detected in ipsilat-
eral HPC (Table 1). At 1 week post-NCSE, more
prominent changes started to occur. Both Iba1 and GFAP
levels were increased in ipsilateral and contralateral HPC at
this time point, whereas NeuN and S100b (Ctrl
100  14.2 vs NCSE 131.3  5.8) levels remained unal-
tered (Figure 2A,D,E). No changes were observed in
cortical and subcortical tissue (Table 1). At 4 weeks post-
NCSE, the GFAP and Iba1 response persisted in contralat-
eral HPC as well as GFAP and S100b on the ipsilateral
side (Figure 2D,E, Table 1). S100b levels remained
unchanged in the contralateral HPC (Ctrl 100  9.4 vs
NCSE 94.3  2.6). Interestingly, NeuN levels were now
decreased in the contralateral HPC (Figure 2A), accompa-
nied by a decrease in NeuN+ cell density in CA1 (Fig-
ure 2C). No changes were detected in CA3, granular cell
layer, or dentate hilus (Table S3). In addition, Iba1+ cell
density was increased in CA1 (Figure 2D) and not in other
HPC subregions (Table S3). No signs of layer dispersion
and differences in thickness were observed on H&E stain-
ing in the HPC (Figure 2C, Table S3). At this time point,
increased Iba1 and decreased NeuN levels were observed
in ipsilateral compared to contralateral HPC tissue from
Ctrl (120.4  14.0 vs 47.8  7.2 and 77.3  12.4 vs
172.3  7.1, respectively), probably due to electrode-
induced damage. This confounder makes analyses of ipsi-
lateral HPC difficult to interpret and may hide possible
changes in NCSE rats. The reduced levels of NeuN in con-
tralateral HPC were accompanied by a decrease in parval-
bumin (PV) and an increase in neuropeptide Y (NPY)
expression (PV, Ctrl 100  9.0 vs NCSE 74.8  3.9;
NPY: Ctrl 100  24.9 vs NCSE 255.2  36.5
respectively), 2 proteins abundant in inhibitory neurons
within the HPC.27 In accordance with earlier time points,
no alterations were observed in cortical tissue whereas
GFAP and S100b levels were increased in subcortex
(Table 1).
3.4 | Decreased levels of synaptic proteins
following NCSE
To determine how NCSE may lead to alterations of the
excitatory/inhibitory balance, we decided to evaluate synap-
tic proteins related to both excitatory (PSD-95, NL-1, N-
cadherin) and inhibitory postsynaptic structures (gephyrin,
NL-2, neurofascin [NF]), as well as presynaptic vesicle-
related proteins (synapsin I and synapsin II). At 6 and
24 hours after NCSE, none of the synaptic proteins was
altered in either ipsi-/contralateral HPC, cortex, or subcor-
tex, except for an increase at 6 hours of NL1,12 an excita-
tory adhesion molecule, within ipsilateral HPC and a
reduction of the excitatory scaffolding protein PSD-95,21,28
a mediator of glutamatergic excitatory synapse clustering in
cortical tissue (Tables 1 and 2).
At 1week post-NCSE, when rats had exhibited acute
symptomatic seizures, levels of PSD-95 and NL-129 were
decreased in the contralateral HPC, whereas the excitatory
synapse-associated adhesion molecule N-cadherin was
unaltered. At the inhibitory synapses, the postsynaptic scaf-
folding protein gephyrin was reduced, but not accompanied
by a change in the adhesion molecule NL-2 or NF.12,21
Synapsin II was reduced, whereas synapsin I levels
remained unaltered (Figure 3). In the ipsilateral HPC, both
NL-2 and synapsin II were reduced (Table 1). Again, pro-
tein levels did not change in the cortex and subcortex,
except for a small decrease in N-cadherin21 levels in the
subcortex (Table 1). At 4 weeks post-NCSE, no changes
in synaptic protein levels were detected in the contralateral
or ipsilateral HPC compared to Ctrl. Similarly, no alter-
ations were detected in the cortex and subcortex, apart
from a minor increase in synapsin II in the cortex (Tables
1 and 2).
3.5 | Development of unprovoked
spontaneous seizures following NCSE
correlates partly to neuronal loss and glial
activation
To assess to what extent the development of spontaneous
seizures after NCSE (ie, epileptogenesis) correlates to the
neuronal loss, glial activation, and changes in synaptic pro-
tein levels, we subdivided the 4-week NCSE rats into 2
groups: rats with only acute symptomatic seizures within
1week (NCSE+AS) and rats with additional spontaneous
seizures during 2-4 weeks post-NCSE (NCSE+SS). The





FIGURE 2 Neuronal loss and glial activation following nonconvulsive status epilepticus (NCSE). Representative images show
immunohistochemical stainings, immunoblots, and quantification of NeuN (46 kDa; A), Fluoro-Jade (FJ; B), NeuN and hematoxylin-eosin (Htx-
Eosin; C), Iba1 (17 kDa; D), and glial fibrillary acidic protein (GFAP; 55 kDa) and S100b (11 kDa; E) at different time points following NCSE
relative to controls (Ctrl). Immunoblots are normalized to glyceraldehyde-3-phosphate dehydrogenase (GAPDH; 37 kDa). Data are presented as
mean  standard error of mean, n = 8 Ctrl and n = 7 NCSE for 6-hour group, n = 8 Ctrl and n = 6 NCSE for immunoblots, and n = 5 Ctrl and
n = 3 NCSE for Fluoro-Jade staining in 24-hour group, n = 6 Ctrl and n = 6 NCSE for 1-week group, and n = 13 Ctrl and n = 16 NCSE for
immunoblots and n = 9 Ctrl and n = 6 NCSE for immunohistochemical analysis of NeuN in 4-week group. *P ≤ .05, unpaired t test.
ML = molecular layer, GCL = granule cell layer within contralateral hippocampus (HPC). Higher magnification in D represents
RAM = ramified, INTER = intermediate, and R/A = round/amoeboid Iba1 morphology. Arrowheads in B, D, and E point toward cells positive
for Fluoro-Jade, Iba1, and GFAP and S100b, respectively. Scale bars represent 500 lm in A-C, 100 lm in D-E, 50 lm in the higher
magnification panel in C, and 10 lm in insets in D and E
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TABLE 1 Quantification of immunoblots of neuronal, microglial, and astrocytic markers and excitatory and inhibitory synaptic proteins in
ipsilateral hippocampus, cortex, and subcortex at 6 hours, 24 hours, 1 week, and 4 weeks post-NCSE
Ipsilateral HPC Cortex Subcortex
Ctrl NCSE Ctrl NCSE Ctrl NCSE
Neurons and glial cells
6 h
NeuN 100  28.9 140.9  25.8 100  18.9 96.2  28.5 100  12.0 142.8  43.8
Iba1 100  167.0 117.1  21.7 100  4.6 84.8  5.5 100  13.2 143.2  31.0
GFAP 100  14.9 93.9  17.2 100  5.9 86.1  8.4 100  41.0 462.7  120.5a
S100b 100  5.6 113.6  9.5 100  29.8 71.9  22.7 100  11.4 117.8  25.8
24 h
NeuN 100  13.9 76.8  18.0 100  24.1 137.7  38.9 100  52.9 38.5  8.3
Iba1 100  6.3 109.4  17.4 100  11.7 85.6  18.6 100  11.6 187.8  57.1
GFAP 100  2.6 107.1  22.9 100  15.9 137.2  26.1 100  9.2 168.3  54.6
S100b 100  5.5 97.5  2.4 100  15.6 76.4  4.3 100  15.3 102.1  23.6
1 wk
NeuN 100  11.8 121.4  10.7 100  17.8 124.3  18.3 100  13.0 108.2  15.9
Iba1 100  14.7 196.6  37.2a 100  21.0 110.9  14.1 100  38.3 93.2  14.6
GFAP 100  18.1 230.3  37.7a 100  33.3 193.8  50.3 100  14.1 133.0  27.3
S100b 100  4.1 85.5  8.7 100  16.0 92.9  14.9 100  3.4 97.9  8.3
4 wk
NeuN 100  24.2 82.5  20.4 100  30.2 73.0  13.8 100  25.5 126.5  23.8
Iba1 100  13.8 108.1  9.6 100  33.1 190.6  46.5 100  19.5 192.9  37.5
GFAP 100  7.6 185.1  14.4a 100  19.8 149.7  35.7 100  14.0 187.2  30.2a
S100b 100  6.8 121.6  6.0a 100  10.2 110.6  9.1 100  13.5 155.6  18.1a
Synaptic proteins
6 h
PSD-95 100  24.7 103.7  32.6 100  8.7 68.7  9.8a 100  25.2 73.7  20.5
NL-1 100  27.4 173.6  15.7a 100  29.2 98.0  32.3 100  44.3 92.1  27.9
N-Cad 100  7.9 109.8  8.3 100  9.3 83.1  16.6 100  58.7 19.3  10.1
Geph 100  10.4 109.8  13.8 100  24.4 75.8  28.6 100  48.4 117.6  43.4
NL-2 100  9.5 110.7  3.8 100  15.3 76.8  15.7 100  10.5 84.7  12.0
NF 100  13.9 134.5  15.5 100  32.6 162.2  45.2 100  19.9 104.8  17.9
Syn I 100  22.9 91.1  19.2 — — — —
Syn II 100  8.3 101.2  7.9 100  12.8 63.1  5.5 — —
24 h
PSD-95 100  21.7 107.9  15.1 100  15.9 95.4  14.7 100  10.4 99.8  21.4
NL-1 100  9.0 77.0  21.8 100  6.4 92.2  6.8 100  7.0 97.0  15.4
N-Cad 100  17.5 55.0  11.1 100  7.7 83.3  13.8 100  13.2 86.8  26.5
Geph 100  3.9 99.4  18.9 100  14.4 75.1  17.1 100  7.1 80.0  14.8
NL-2 100  6.9 82.5  10.4 100  16.8 99.5  14.7 100  13.5 61.2  10.4
NF 100  24.9 37.1  9.6 100  18.1 95.3  20.8 100  19.2 53.3  6.2
Syn I 100  5.4 97.5  7.9 100  11.8 97.5  11.4 100  3.0 108.1  4.7
Syn II 100  23.2 142.6  55.6 100  14.4 115.5  9.4 100  9.5 95.7  13.5
(Continues)
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decrease in NeuN levels in the contralateral HPC following
NCSE shown for the entire group was now only significant
in rats that developed spontaneous seizures. No decrease
was observed in rats with only acute symptomatic seizures;
however, there was a trend (P = .052; Figure 4A). The
lack of changes in cortical and subcortical tissue remained
when subdividing the NCSE rats (cortex: Ctrl 100  30.2
vs NCSE+AS 39.1  18.9 vs NCSE+SS 76.5  12.0;
TABLE 1 (Continued)
Ipsilateral HPC Cortex Subcortex
Ctrl NCSE Ctrl NCSE Ctrl NCSE
1 wk
PSD-95 100  2.4 79.9  9.1 100  14.6 93.14  8.6 100  10.8 95.5  18.0
NL-1 100  4.2 105.6  3.8 100  10.1 90.7  7.9 100  6.5 89.5  4.6
N-Cad 100  5.2 114.9  7.5 100  5.5 84.4  6.2 100  4.5 84.8  4.2a
Geph 100  1.7 97.2  3.1 100  20.4 80.1  15.4 100  5.6 120.2  19.8
NL-2 100  4.8 86.9  2.1a 100  12.0 98.0  5.7 100  11.1 109  18.7
NF 100  4.0 99.1  2.5 100  12.1 123.9  20.3 100  18.2 91.5  6.7
Syn I 100  7.2 78.8  8.6 100  15.8 106.8  14.7 100  10.5 91.0  15.2
Syn II 100  7.5 59.8  10.0a 100  9.7 80.2  8.5 100  9.3 94.8  14.4
4 wk
PSD-95 100  16.9 84.9  12.6 100  9.4 100.7  18.7 100  20.3 149.5  51.1
NL-1 100  15.3 68.7  9.6 100  7.8 110.8  6.2 100  30.0 166.2  29.0
N-Cad 100  15.6 119.7  15.1 100  6.8 87.6  6.3 100  15.8 84.5  14.6
Geph 100  6.2 113.7  13.7 100  16.2 104.6  10.0 100  22.9 126.0  32.8
NL-2 100  13.2 120.5  16.8 100  14.4 114.8  22.8 100  9.2 119.9  10.8
NF 100  16.0 103.4  12.8 100  15.2 66.4  9.1 100  30.5 117.0  26.5
Syn I 100  12.9 119.2  16.3 100  6.1 90.3  6.5 100  18.0 130.7  26.5
Syn II 100  9.8 95.5  6.6 100  9.6 123.8  3.2a 100  6.9 112.5  15.1
Data (mean  standard error of mean) are presented as percentage change relative to Ctrl and normalized to either b-actin (42 kDa) or glyceraldehyde-3-phosphate
dehydrogenase (37 kDa). 6 h: Ctrl, n = 6-8; NCSE, n = 7. 24 h: Ctrl, n = 6-8; NCSE, n = 5-6. 1 wk: Ctrl, n = 6; NCSE, n = 4-6. 4 wk: Ctrl, n = 5-12; NCSE, n
= 5-16. Bold figures represent significant differences compared to Ctrl.
Ctrl, controls; Geph, gephyrin; GFAP, glial fibrillary acidic protein; HPC, hippocampus; N-Cad, N-cadherin; NCSE, nonconvulsive status epilepticus; NF, neuro-
fascin; NL, neuroligin; PSD, postsynaptic density protein; Syn, synapsin.
aP ≤ .05, unpaired t test.
TABLE 2 Quantification of immunoblots of excitatory and inhibitory synaptic proteins in contralateral hippocampus at 6 hours, 24 hours,
and 4 weeks post-NCSE
6 h 24 h 4 wk
Ctrl NCSE Ctrl NCSE Ctrl NCSE
PSD-95 100  6.1 93.4  7.1 100  10.3 101.8  6.0 100  20.6 85.9  14.2
NL-1 100  21.9 92.0  19.5 100  18.3 123.4  17.2 100  11.7 102.5  11.5
N-cadherin 100  12.6 110.1  10.5 100  7.8 96.4  7.9 100  7.0 85.8  6.2
Gephyrin 100  8.6 86.0  6.3 100  17.1 113.1  7.8 100  2.5 103.1  4.2
NL-2 100  10.8 85.2  15.7 100  11.4 99.7  19.3 100  8.5 110.9  101.0
Neurofascin 100  20.1 92.6  17.0 100  28.9 60.2  14.6 100  11.2 128.0  13.8
Synapsin I 100  20.5 101.9  28.8 100  9.5 101.3  13.9 100  6.3 88.4  8.1
Synapsin II 100  30.3 46.2  13.7 100  16.0 97.0  12.7 100  6.7 83.1  12.9
Data (mean  standard error of mean) are presented as percentage change relative to Ctrl and normalized to either b-actin (42 kDa) or glyceraldehyde-3-phosphate
dehydrogenase (37 kDa). 6 h: Ctrl, n = 8; NCSE, n = 7. 24 h: Ctrl, n = 6; NCSE, n = 6. 1 wk: Ctrl, n = 5-6; NCSE, n = 4-6. 4 wk: Ctrl, n = 7-12; NCSE, n = 7-
16.
Ctrl, controls; NCSE, nonconvulsive status epilepticus; NL, neuroligin; PSD, postsynaptic density protein.
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subcortex: Ctrl 100  25.5 vs NCSE+AS 86.0  35.0 vs
NCSE+SS 146.6).
The increase in Iba1 levels in the contralateral HPC at
4 weeks post-NCSE was evident in both the acute symp-
tomatic and spontaneous seizure group, whereas rats with
acute symptomatic seizures contributed the most to the
overall increase in GFAP (Figure 4B,C). In contrast to pre-
vious measurements of the entire NCSE group, Iba1 levels
were now also increased in both cortex and subcortex (cor-
tex: Ctrl 100  33.1 vs NCSE+AS 52.6  24.6 vs
NCSE+SS 232  53.6; subcortex Ctrl 100  19.5 vs
NCSE+AS 143  65.0 vs NCSE+SS 230  52.4), and
GFAP levels were increased in subcortex in rats with
NCSE and spontaneous seizures compared to Ctrl (Ctrl
100  14.0 vs NCSE+AS 164.8  73.0 vs NCSE+SS
213.9  37.4). Levels of S100b expression remained
unchanged in contralateral HPC (Figure 4D) and cortex,
whereas rats with spontaneous seizures exhibited an
increase in subcortical tissue (Ctrl 100  13.5 vs
NCSE+AS 120.3  24.3 vs NCSE+SS 171.7  26.0).
Again, due to possible electrode-induced changes, we
detected no alterations in the ipsilateral HPC in NeuN and
Iba1 levels, whereas GFAP levels were increased in both
groups (Ctrl 100  7.6 vs NCSE+AS 152.2  31.3 vs
NCSE+SS 206.9  16.3) and S100b levels were increased
in rats with spontaneous seizures compared to Ctrl (Ctrl
FIGURE 3 Excitatory and inhibitory synaptic protein alterations in the hippocampus 1 week after nonconvulsive status epilepticus (NCSE).
Representative immunohistochemical stainings and immunoblots and quantification are shown of postsynaptic density protein 95 (PSD-95;
95 kDa), neuroligin-1 (NL-1; 101 kDa), N-cadherin (120 kDa) gephyrin (95 kDa), neuroligin-2 (NL-2; 93 kDa), neurofascin (NF; 155 kDa),
synapsin I (75 kDa), and synapsin II (54 and 74 kDa) in contralateral hippocampus, relative to Ctrl, and normalized to either b-actin (42 kDa) or
glyceraldehyde-3-phosphate dehydrogenase (GAPDH; 37 kDa). Data are presented as mean  standard error of mean; controls (Ctrl), n = 5-6;
NCSE, n = 4-6. *P ≤ .05, unpaired t test. Arrowheads in photomicrographs point toward clusters of synaptic proteins. Scalebar = 5 lm for all
parts
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100  6.8 vs NCSE+AS 120.9  12.0 vs NCSE+SS
121.8  7.2).
3.6 | Decreased N-cadherin levels in NCSE
rats with spontaneous compared to acute
symptomatic seizures
Rats with spontaneous seizures post-NCSE exhibited
decreased levels of N-cadherin in the contralateral HPC
compared to rats with only acute symptomatic seizures
(Figure 4E). The reduction did not correlate with reduced
NeuN levels (r = .071, P = .91), suggesting that the N-
cadherin reduction was not a result of neuronal death. Also,
N-cadherin levels within the NCSE group exhibiting spon-
taneous seizures did not correlate with the total number or
duration of spontaneous seizures per rat during week 2-4
(r = .56, P = .19 and r = .49, P = .26, respectively), mean
duration of individual spontaneous seizures (r = .04,
P = .94), or IA load during the same period (r = .29,
P = .56). This may suggest a common underlying course
for reduced N-cadherin expression in NCSE rats develop-
ing spontaneous seizures, rather than a decrease due to the
spontaneous seizures per se. No changes were observed in
the ipsilateral HPC, cortical, or subcortical tissue (Fig-
ure 4F-H).
4 | DISCUSSION
Apart from being difficult to diagnose in patients, the long-
term consequences of NCSE per se have so far been diffi-
cult to visualize with standard imaging techniques and
FIGURE 4 Differences in protein levels of nonconvulsive status epilepticus (NCSE) rats developing spontaneous seizures compared to only
acute symptomatic seizures. Representative immunoblots and quantification are shown of (A) NeuN (46 kDa), (B) Iba1 (17 kDa), (C) glial
fibrillary acidic protein (GFAP; 55 kDa), (D) S100b (11 kDa), and (E) N-cadherin (120 kDa) in contralateral hippocampus (cHPC), (F) N-
cadherin in ipsilateral hippocampus (iHPC), (G) N-cadherin in cortex, and (H) N-cadherin in subcortex at 4 weeks after NCSE with either
spontaneous seizures (SS) or acute symptomatic seizures (AS) relative to controls (Ctrl), and normalized to either b-actin (42 kDa) or
glyceraldehyde-3-phosphate dehydrogenase (GAPDH; 37 kDa). Data are presented as mean  standard error of mean; Ctrl, n = 7-13; NCSE+SS,
n = 3-10; NCSE+AS, n = 3-4. *P ≤ .05, unpaired t test
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remain unclear. Here we provide evidence for neuronal
loss, continuous immune reaction, and alterations in excita-
tory and inhibitory synaptic proteins in the temporal lobes
within 1 month following complex partial NCSE in rats.
The histopathology in this experimental model could not
be consistently confirmed by DTI of mice with similar
NCSE. We noticed that a majority of the animals had no
latency period but experienced acute symptomatic seizures
during the first week post-NCSE. About 70% of them con-
tinued to develop an epileptogenic phase with unprovoked
spontaneous focal seizures with or without secondary gen-
eralization and IA. NCSE rats that developed spontaneous
seizures exhibited an immune reaction that extended out-
side the epileptic focus and into cortical tissue. In addition,
levels of the synaptic adhesion molecule N-cadherin were
specifically decreased in the HPC of NCSE rats with con-
comitant spontaneous seizures, indicating its involvement
in the development of epilepsy.
There are few experimental models that mimic NCSE.
Low doses of pilocarpine/kainic acid can initiate noncon-
vulsive seizures/SE,7,8,30,31 although so far either primarily
cortical brain damage or more extensive HPC damage has
been reported. Studies on the intrahippocampal kainic acid
model describe NCSE in mice for up to 10 hours, followed
by a latent phase without acute symptomatic seizures for
2 weeks, before the development of spontaneous seizures.
The subsequent pathophysiology shows similarities to HPC
sclerosis.10 The electrical-induced models for epileptic sei-
zures11 have been utilized extensively for initiating more
severe secondary generalized seizures/SE. In the present
study, we have instead initiated NCSE with temporal semi-
ology and seldom secondary generalization.11,17 In clinical
practice, many patients present comorbidities, which makes
pathology related to the NCSE per se difficult to dissect
out. The animals in the electrical model were naive before
electrode implantation, meaning no other underlying
genetic pathology or acquired factors for epilepsy were pre-
sent. In addition, no drugs were administered to initiate the
seizures. Neither the amount of acute symptomatic seizures
nor the load of IA predicted the risk of developing sponta-
neous seizures, which underscores the importance of
exploring new biomarkers for epileptogenesis. Almost all
of the NCSE rats developed acute symptomatic seizures,
but 30% did not continue with spontaneous seizures within
4 weeks post-NCSE. It is possible that some rats would
have developed seizures at later time points, but the data
still support previous clinical studies suggesting that acute
symptomatic seizures cannot be used as a strong predictor
of epileptogenesis even if they are associated with an
increased risk.19,20,32,33
We conclude from the current study that ex vivo DTI at
9.4 T did not provide convincing results for detection of
microstructural changes within the epileptic focus following
experimental NCSE without extensive HPC sclerosis.
Power calculations (P = .80) suggest an additional sample
size of >10 mice per group to detect differences in FA.
However, the presented 9.4-T DTI FA maps were included
primarily to shed light on the problem that, on an individ-
ual level, cellular alterations after NCSE are variable and
sometimes undetectable. Given that the current first-line
tool for investigating epileptic insults is 1.5–3-T MRI scan-
ners and that few studies have been able to localize long-
lasting changes in the brain following NCSE,5,6 future
studies may have to combine more advanced MRI methods
with other imaging techniques, such as new positron emis-
sion tomography isotopes, to increase the sensitivity for
seizure-induced changes.
With only minor exceptions, the increase in glial activa-
tion and neuronal loss at 1 and 4 weeks post-NCSE was
most prominent in the epileptic focus, particularly in the
CA1 region of the HPC. Changes in subgroups of cortical
and subcortical neurons may be missed due to sensitivity
limits of the Western blot analyses. Nonetheless, within the
epileptic focus small changes in protein levels related to
inhibitory neurons were observed, which strengthens previ-
ous immunohistochemical findings.17 Early neurodegenera-
tion post-NCSE within CA regions further supports the
finding of neuronal cell loss. In addition, the Iba1 and
GFAP levels peaked at 1 week, concurrently with a previ-
ously described increase in cells expressing the glial marker
ED1.18 Whether the inflammatory profile may exhibit
proinflammatory or anti-inflammatory properties is not
revealed by levels of Iba1, GFAP, or S100b. A heteroge-
nous immune profile has also been described for hippocam-
pal, cortical, and cerebellar areas following a similar
electrical SE model of nonconvulsive plus convulsive sei-
zures.26 The present finding with an altered morphology of
microglia within the HPC merely suggests a more activated
profile. Preliminary data from our group indicate a transient
early HPC increase and systemic release of cytokines and
chemokines already 6 hours post-NCSE (Avdic et al,
unpublished observations). Additionally, in NCSE rats that
developed spontaneous seizures, a cortical glial reaction
could indicate larger network involvement, which is sup-
ported by clinical functional MRI studies of temporal lobe
epilepsy.34
The glial reaction was accompanied by a transient
acute rearrangement of excitatory and inhibitory synaptic
properties. The overall decrease in pivotal synaptic pro-
teins may either propagate the pathophysiology and
increase the susceptibility for having or initiating sponta-
neous seizures or merely reflect a dampening reaction to a
prolonged abnormal synchronized activity as that of
NCSE. Irrespectively, the synaptic reaction may be
involved in the development of epilepsy. We have previ-
ously documented alterations in the same synaptic proteins
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prior to the occurrence of provoked generalized seizures
in genetically modified mice depleted of synapsin II,21
and gephyrin levels are reduced after pilocarpine-induced
convulsive SE.35 Several of these synaptic proteins can
also be disrupted in patients with epilepsy.36–39 At
4 weeks post-NCSE, only levels of the excitatory adhe-
sion molecule N-cadherin were reduced in epileptic rats,
compared to rats with acute symptomatic seizures. Selec-
tive loss of N-cadherin by conditional ablation of excita-
tory synapses has been shown to increase the density of
inhibitory synaptic proteins and decrease PSD-95, suggest-
ing a seizure-promoting effect for N-cadherin.40
The functional consequences for cognition and other
behavioral tasks post-NCSE are not clear. Although previ-
ous studies have reported altered social interaction and
motor deficits in rats following NCSE induced by low-dose
pilocarpine,31 the long-term pathology detected in our
model is not associated with changes in spatial working
memory assessed with Y-maze, forced swim test, or open
field and social interaction test for signs of depression, anx-
iety or impaired social behavioral traits, respectively (Avdic
et al, unpublished observations).
5 | CONCLUSION
Our report provides evidence for an experimental rodent
model of NCSE with several similarities to clinical practice
in terms of periictal and interictal EEG patterns, semiology,
and development of acute symptomatic and spontaneous
seizures. It describes the ignition of long-lasting NCSE-
induced pathophysiological changes in the brain, including
neuronal loss, immune reaction, and synaptic rearrange-
ments, which are not readily detected with high-resolution
DTI imaging. The model is also promising for future clini-
cal predictions of biomarkers and therapeutic strategies for
epilepsy.
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